-
SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020
- Sheila F Lumley1,2,3 , David W Eyre1,2,3,4 , Anna L McNaughton1,3 , Alison Howarth5 , Sarah Hoosdally5 , Stephanie B Hatch6 , James Kavanagh5 , Kevin K Chau5 , Louise O Downs2 , Stuart Cox7 , Laura Dunn2 , Anita Justice2 , Susan Wareing2 , Kate Dingle5 , Justine Rudkin4 , Kathryn Auckland5 , Alexander Fyfe8 , Jai Bolton8 , Robert Paton8 , Alexander J Mentzer2,5 , Katie Jeffery2 , Monique I Andersson2 , Tim James7 , Tim E A Peto2,5 , Brian D Marsden9,10,11 , Gavin Screaton12 , Richard J Cornall12 , Paul Klenerman1,2,5 , Daniel Ebner6 , David I Stuart6,10,11 , Derrick W Crook2,5 , Nicole Stoesser2,5 , Stephen H Kennedy13 , Craig Thompson8 , Sunetra Gupta8 , Philippa C Matthews1,2,3,5
-
View Affiliations Hide AffiliationsAffiliations: 1 Nuffield Department of Medicine, University of Oxford, Medawar Building, South Parks Road, Oxford, United Kingdom 2 Department of Microbiology/Infectious Diseases, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom 3 These authors contributed equally to this work 4 Nuffield Department of Population Health, University of Oxford, Big Data Institute, Old Road Campus, Oxford, United Kingdom 5 Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, United Kingdom 6 Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Big Data Institute, Old Road Campus, Oxford, United Kingdom 7 Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom 8 Department of Zoology, University of Oxford, Medawar Building, South Parks Road, Oxford, United Kingdom 9 Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Old Road Campus, Roosevelt Drive, Headington, Oxford, United Kingdom 10 Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, United Kingdom 11 The Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Henry Wellcome Building, Roosevelt Dr, Headington, Oxford, United Kingdom 12 Wellcome Centre for Human Genetics, Nuffield Department of Medicine, Roosevelt Drive, Headington, Oxford, United Kingdom 13 Nuffield Department of Women’s & Reproductive Health, University of Oxford, John Radcliffe Hospital, Oxford, United KingdomPhilippa C Matthewsphilippa.matthews ndm.ox.ac.uk
-
View Citation Hide Citation
Citation style for this article: Lumley Sheila F, Eyre David W, McNaughton Anna L, Howarth Alison, Hoosdally Sarah, Hatch Stephanie B, Kavanagh James, Chau Kevin K, Downs Louise O, Cox Stuart, Dunn Laura, Justice Anita, Wareing Susan, Dingle Kate, Rudkin Justine, Auckland Kathryn, Fyfe Alexander, Bolton Jai, Paton Robert, Mentzer Alexander J, Jeffery Katie, Andersson Monique I, James Tim, Peto Tim E A, Marsden Brian D, Screaton Gavin, Cornall Richard J, Klenerman Paul, Ebner Daniel, Stuart David I, Crook Derrick W, Stoesser Nicole, Kennedy Stephen H, Thompson Craig, Gupta Sunetra, Matthews Philippa C. SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020. Euro Surveill. 2020;25(42):pii=2001721. https://doi.org/10.2807/1560-7917.ES.2020.25.41.2001721 Received: 24 Sept 2020; Accepted: 22 Oct 2020
Abstract
SARS-CoV-2 IgG screening of 1,000 antenatal serum samples in the Oxford area, United Kingdom, between 14 April and 15 June 2020, yielded a 5.3% seroprevalence, mirroring contemporaneous regional data. Among the 53 positive samples, 39 showed in vitro neutralisation activity, correlating with IgG titre (Pearson’s correlation p<0.0001). While SARS-CoV-2 seroprevalence in pregnancy cohorts could potentially inform population surveillance, clinical correlates of infection and immunity in pregnancy, and antenatal epidemiology evolution over time need further study.
Article metrics loading...
Full text loading...
References
-
Statistical bulletin: Coronavirus (COVID-19) Infection Survey pilot: England, 25 June 2020. Office for National Statistics, in partnership with IQVIA, Oxford University and UK Biocentre. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/latest
-
Emmenegger M, De Cecco E, Lamparter D, Jacquat RPB, Ebner D, Schneider MM, et al. Early plateau of SARS-CoV-2 seroprevalence identified by tripartite immunoassay in a large population. medRxiv. 2020; 2020.05.31.20118554.
-
National SARS-CoV-2 Serology Assay Evaluation Group. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison. Lancet Infect Dis. 2020;S1473-3099(20)30634-4. PMID: 32979318
-
Thompson C, Grayson N, Paton R, Lourenço J, Penman B, Lee LN, et al. Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors - a pilot study of the value of serology to determine population exposure. Infectious Diseases (except HIV/AIDS). medRxiv; 2020. doi: https://doi.org/10.1101/2020.04.13.20060467
-
Nie J, Li Q, Wu J, Zhao C, Hao H, Liu H, et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect. 2020;9(1):680-6. https://doi.org/10.1080/22221751.2020.1743767 PMID: 32207377
-
Suthar MS, Zimmerman MG, Kauffman RC, Mantus G, Linderman SL, Hudson WH, et al. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients. Cell Rep Med. 2020;1(3):100040. https://doi.org/10.1016/j.xcrm.2020.100040 PMID: 32835303
-
Peterhoff D, Glück V, Vogel M, Schuster P, Schütz A, Neubert P, et al. A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization. Infection. 2020. https://doi.org/10.1007/s15010-020-01503-7 PMID: 32827125
-
Sood N, Simon P, Ebner P, Eichner D, Reynolds J, Bendavid E, et al. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020. JAMA. 2020;323(23):2425-7. https://doi.org/10.1001/jama.2020.8279 PMID: 32421144
-
Percivalle E, Cambiè G, Cassaniti I, Nepita EV, Maserati R, Ferrari A, et al. Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020. Euro Surveill. 2020;25(24):2001031. https://doi.org/10.2807/1560-7917.ES.2020.25.24.2001031 PMID: 32583766
-
Eyre DW, Lumley SF, O’Donnell D, Campbell M, Sims E, Lawson E, et al. , Oxford University Hospitals Staff Testing Group. Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study. eLife. 2020;9:e60675. https://doi.org/10.7554/eLife.60675 PMID: 32820721
-
Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S, et al. , Cochrane COVID-19 Diagnostic Test Accuracy Group. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev. 2020;6:CD013652. PMID: 32584464
-
Buekens P, Alger J, Bréart G, Cafferata ML, Harville E, Tomasso G. A call for action for COVID-19 surveillance and research during pregnancy. Lancet Glob Health. 2020;8(7):e877-8. https://doi.org/10.1016/S2214-109X(20)30206-0 PMID: 32333854
-
Corbett GA, Milne SJ, Hehir MP, Lindow SW, O’connell MP. Health anxiety and behavioural changes of pregnant women during the COVID-19 pandemic. Eur J Obstet Gynecol Reprod Biol. 2020;249:96-7. https://doi.org/10.1016/j.ejogrb.2020.04.022 PMID: 32317197
-
Mattern J, Vauloup-Fellous C, Zakaria H, Benachi A, Carrara J, Letourneau A, et al. Post lockdown COVID-19 seroprevalence and circulation at the time of delivery, France. Infectious Diseases (except HIV/AIDS). medRxiv; 2020. doi: https://doi.org/10.1101/2020.07.14.20153304
-
Cosma S, Borella F, Carosso A, Sciarrone A, Cusato J, Corcione S, et al. The "scar" of a pandemic: Cumulative incidence of COVID-19 during the first trimester of pregnancy. J Med Virol. 2020;jmv.26267. https://doi.org/10.1002/jmv.26267 PMID: 32633869
-
Crovetto F, Crispi F, Llurba E, Figueras F, Gómez-Roig MD, Gratacós E. Seroprevalence and presentation of SARS-CoV-2 in pregnancy. Lancet. 2020;396(10250):530-1. https://doi.org/10.1016/S0140-6736(20)31714-1 PMID: 32771084
-
Galang RR, Chang K, Strid P, Snead MC, Woodworth KR, House LD, et al. Severe Coronavirus Infections in Pregnancy: A Systematic Review. Obstet Gynecol. 2020;136(2):262-72. https://doi.org/10.1097/AOG.0000000000004011 PMID: 32544146
-
Cohen J, Vignaux O, Jacquemard F. Covid-19 in pregnant women: General data from a French National Survey. Eur J Obstet Gynecol Reprod Biol. 2020;251:267-8. https://doi.org/10.1016/j.ejogrb.2020.06.002 PMID: 32540156
-
Maleki Dana P, Kolahdooz F, Sadoughi F, Moazzami B, Chaichian S, Asemi Z. COVID-19 and pregnancy: a review of current knowledge. Infez Med. 2020;28(suppl 1):46-51. PMID: 32532938
-
Maraschini A, Corsi E, Salvatore MA, Donati S. Coronavirus and birth in Italy: results of a national population-based cohort study. Obstetrics and Gynecology. medRxiv; 2020. doi: https://doi.org/10.1101/2020.06.11.20128652
-
INTERCOVID • INTERGROWTH-21st. [Accessed 1 Jul 2020]. Available from: https://intergrowth21.tghn.org/intercovid/
-
Coronavirus (COVID-19) in the UK. [Accessed 16 Sep 2020]. Available from: https://coronavirus.data.gov.uk/cases
-
World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. Geneva: WHO. [Accessed 16 Sep 2020]. Available from: https://covid19.who.int/
Data & Media loading...
Supplementary data
-
-
Supplementary Material
-